Two Cases of Humoral Hypercalcemia of Malignancy in Metastatic Cholangiocarcinoma
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Humoral hypercalcemia of malignancy (HHM) is rarely associated with cholangiocarcinoma (CC), and represents dismal prognosis. A 63-year-old male was admitted for evaluation of an intrahepatic mass. He was diagnosed with HHM associated with locally advanced CC. As the tumor responded to the concurrent chemoradiotherapy with capecitabine and cisplatin, serum calcium level was normalized. However,according to the disease progression, he suffered recurrence of HHM and he expired approximately one year after initial diagnosis. A 68-year-old male who presented with abdominal pain was diagnosed with metastatic CC. After the eighth cycle of gemcitabine and cisplatin, progression of the disease was found with HHM. He was treated with the best supportive care, until his demise approximately one month after the diagnosis of HHM. We report on two cases of HHM associated with CC that demonstrate strong correlation between hypercalcemia and disease burden.
Abstract
Humoral hypercalcemia of malignancy (HHM) is rarely associated with cholangiocarcinoma (CC), and represents dismal prognosis. A 63-year-old male was admitted for evaluation of an intrahepatic mass. He was diagnosed with HHM associated with locally advanced CC. As the tumor responded to the concurrent chemoradiotherapy with capecitabine and cisplatin, serum calcium level was normalized. However,according to the disease progression, he suffered recurrence of HHM and he expired approximately one year after initial diagnosis. A 68-year-old male who presented with abdominal pain was diagnosed with metastatic CC. After the eighth cycle of gemcitabine and cisplatin, progression of the disease was found with HHM. He was treated with the best supportive care, until his demise approximately one month after the diagnosis of HHM. We report on two cases of HHM associated with CC that demonstrate strong correlation between hypercalcemia and disease burden.
참고문헌 (13)
- Stewart AF, "Clinical practice: hypercalcemia associated with cancer", N Engl J Med, 352, pp.373~379 (2005)
- Stewart AF, "Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups", N Engl J Med, 303, pp.1377~1383 (1980)
- Hall FM, "Cisplatin plus gemcitabine for biliary tract cancer", N Engl J Med, 363, pp.192~ (2010)
- Oldenburg WA, "Sheedy PF 2nd. Hypercalcemia and primary hepatic tumors", Arch Surg, 117, pp.1363~1366 (1982)
- Trikudanathan G, "Cholangiocarcinoma and paraneoplastic hypercalcemia: a lethal combination revisited", South Med J, 103, pp.716~718 (2010)
- Clines GA, "Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone", Endocr Relat Cancer, 12, pp.549~583 (2005)
- Kovacs CS, "Hypercalcemia of malignancy in the palliative care patient: a treatment strategy", J Pain Symptom Manage, 10, pp.224~232 (1995)
- Yen Y, "Paraneoplastic syndromes in cancer: case 3. Parathyroid hormone-related hypercalcemia in cholangiocarcinoma", J Clin Oncol, 22, pp.2244~2245 (2004)
- Yamada M, "Cholangiocarcinoma producing parathyroid hormone-related peptide treated with chemoradiation using gemcitabine and S-1", Intern Med, 48, pp.2097~2100 (2009)
- Maarouf A, "Mixed hepato", cholangiocarcinoma with paraneoplastic hypercalcemia, 2008, pp.15, 224~227
- Macdonald OK, "Palliative and postoperative radiotherapy in biliary tract cancer", Surg Oncol Clin N Am, 11, pp.941~954 (2002)
- Czito BG, "Radiation therapy in the treatment of cholangiocarcinoma", Oncology, 20, pp.873~884 (2006)
- Das P, "Concurrent capecitabine and upper abdominal radiation therapy is well tolerated", Radiat Oncol, 1, pp.41~ (2006)